For decades, men with the disease faced a binary choice: live with the cancer, or live with the consequences of removing it. This doctor is pushing an alternative that he says is more precise, humane ...
It’s the second most common type of cancer among men and affects 1 in every 8 men in the United States. September is Prostate Cancer Awareness Month, and the American Cancer Society says this type of ...
PANAMA CITY, Fla. (WJHG/WECP) - Hope Regional Medical Center in Panama City is now using a powerful new diagnostic tool in the fight against Prostate Cancer. Doctors at the center have always used CT ...
The Brighterside of News on MSN
New drug combination stops prostate cancer growth in phase 3 clinical trial
An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...
SAN ANTONIO, Texas, September 18, 2025--(BUSINESS WIRE)--NucleoBio, Corp., a leading biotechnology innovator in precision oncology diagnostics, and PreCheck Health Services, a high-complexity ...
A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...
Test aims to help clinicians decide whether patients who test negative will need further biopsy procedures. FDA approved Gen-Probe’s Progensa® PCA3 (Prostate Cancer gene 3) assay, which the firm ...
British retiree David Butler was surprised to find that he had prostate cancer, and that it had spread to the lymph nodes and other places near the prostate. "I had literally no symptoms apart from ...
WASHINGTON (Reuters) - U.S. regulators are investigating potential risks from Abbott Laboratories Inc's HIV drug Kaletra, GlaxoSmithKline Plc's prostate drug Avodart and other medicines. The Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback